Investing in dividend-paying stocks like Bristol Myers Squibb and Royalty Pharma can provide steady income, with both companies rapidly increasing their payouts. Bristol Myers Squibb, with a 4.9% yield, has raised its dividend for 15 consecutive years and has multiple growth drivers. Royalty Pharma, offering a 2.9% yield, has seen a 60% increase in free cash flow since 2020 and is poised for exponential growth in royalties and dividends.